ArticleBMC infectious diseases2026
The burden of COVID-19-related intensive care admissions in the Nordic countries, 2020-2023.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic caused a significant burden on populations and intensive care units (ICU) globally. We assessed the population burden of admissions to the ICU with COVID-19 in the Nordic countries in 2020-2023 to inform pandemic planning.
methodsWe used data from national health registries and applied national case definitions to identify patients admitted to the ICU with and due to confirmed COVID-19. We calculated cumulative incidence per 100,000 inhabitants by country, and described the characteristics of the patients including age, sex, and disease severity.
resultsIn 2020-2023, 21,587 patients were admitted to the ICU with COVID-19, of whom > 13,000 patients were admitted due to COVID-19. Sweden had the highest cumulative incidence of patients admitted due to COVID-19 (78.5 per 100,000, n = 8,179), and a peak incidence twice that of the other countries. The median age of ICU patients increased over time in all countries, and the majority (62-72%) of patients were men. The longest length of stay in 2020-2021 was recorded in Norway (median 14, lower - upper quartile 7.0-23.5 days), and it decreased to 2, 3 or 4 days in most countries in 2022-2023. Seventy-nine percent of patients received ventilatory support and 25% of patients died, with increasing in-ICU mortality in Norway and Sweden towards 2023. Differences in data sources and case definitions limited the comparability of data from the countries.
conclusionsThe burden of ICU admissions with COVID-19 varied in the Nordic countries and was associated with non-modifiable factors like age and sex, and evolving ones including virus dynamics, and increasing population immunity. Even in the presence of vaccination programmes with documented effectiveness against severe disease, ICUs should be prepared to treat patient groups with suboptimal responses to vaccination. Continued collaboration between the Nordic countries, including the harmonisation of case definitions and protocols for future studies, will improve pandemic preparedness. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.